Slideshow

8 Reasons a Psychotropic Medication May Be Discontinued

Author(s):

John J. Miller, MD

Tips for having a balanced and comprehensive risk-to-benefit discussion with competent patients who want to stop their medications.

This article was originally posted on January 28, 2015 and has since been updated.

Related Videos
cognition
clock
clozapine
steering wheel
schizophrenia
Christoph U. Correll
John Kane
World Bipolar Day
clozapine
Related Content
FDA
April 1st 2025

New NDA Submitted: Bysanti to Treat Acute Bipolar I and Schizophrenia

Leah Kuntz
Treating ‘Morally Objectionable’ Patients
September 27th 2021

Treating ‘Morally Objectionable’ Patients

James L. Knoll IV, MD
schizophrenia
March 31st 2025

Phase 2 Trial Open Enrollment for SPG302, First Synaptic Regenerative Approach to Treat Schizophrenia

Leah Kuntz
Blue Light, Depression, and Bipolar Disorder
August 4th 2021

Blue Light, Depression, and Bipolar Disorder

Chris Aiken, MD Kellie Newsome, PMH-NP
insurance
March 21st 2025

Difficulties With Insurance and Patient Care: “Why Is the System So Complicated?”

Nidal Moukaddam, MD, PhD Asim A. Shah, MD Aletheia Phoenix, MD
bipolar
March 14th 2025

How to Decide Whether Depressions Are Bipolar Depressions

David N. Osser, MD
© 2025 MJH Life Sciences

All rights reserved.